| 000 | 00936 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515020103.0 | ||
| 264 | 0 | _c20060407 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/CIRCULATIONAHA.105.609271 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGössl, M | |
| 245 | 0 | 0 |
_aEndothelin: beyond a vasoconstrictor. _h[electronic resource] |
| 260 |
_bCirculation _cMar 2006 |
||
| 300 |
_a1156-8 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial; Review | ||
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdrug therapy |
| 650 | 0 | 4 | _aEndothelin Receptor Antagonists |
| 650 | 0 | 4 |
_aEndothelin-1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xtherapeutic use |
| 700 | 1 | _aLerman, A | |
| 773 | 0 |
_tCirculation _gvol. 113 _gno. 9 _gp. 1156-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCULATIONAHA.105.609271 _zAvailable from publisher's website |
| 999 |
_c16130183 _d16130183 |
||